"Designing Growth Strategies is in our DNA"

Acute Respiratory Distress Syndrome Treatment Market Size, Share and Global Trend By Drug Class (Vasoconstrictors, Bronchodilators, Steroids and Antibiotics, Nitric Oxide, Sedatives & Paralytics, Surfactant), By Route of Administration (Oral, Injection, Inhalation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Geography Forecast till 2021-2028

Region : Global | Report ID: FBI101180 | Status : Ongoing

 

KEY MARKET INSIGHTS

Acute respiratory distress syndrome (ARDS) refers to a medical condition in which the lungs are not able to take up an adequate amount of oxygen and supply to other vital organs. It occurs due to the accumulation of fluids in alveoli, preventing the lungs from filling up enough amount of air due to which less oxygen reaches the bloodstream. Acute respiratory distress syndrome often results from another underlying cause such as sepsis, severe pneumonia, inhalation of harmful substances, head, chest, or another major injury.


The symptoms of acute respiratory distress syndrome include low blood pressure, severe shortness of breath, unusually rapid breathing, confusion and extreme tiredness, and others. The cases of acute respiratory distress syndrome among infants are gradually increasing. The common treatment methods for acute respiratory distress syndrome is through mechanical ventilation, IV fluids, inhaled medications such as nitric oxide, surfactants, and others.


To gain extensive insights into the market, Request for Customization


Increase in investment in research by both government and private organization have led to a huge upsurge in global acute respiratory distress syndrome treatment market. For example, HEALIOS K.K, a company focussed on developing cellular and regeneration medicines, acquired the development and commercialization rights of MultiStem, a stem cell product under clinical study for acute respiratory distress syndrome, which is anticipated to accelerate the global acute respiratory distress syndrome treatment market growth.


Global acute respiratory distress syndrome treatment market growth is being driven by the emerging guidelines for the management of acute respiratory distress syndrome, potential pipeline products, and rise in a number of neonatal intensive care units. Furthermore, increased research on stem cell and strategic collaborations to develop treatment of acute respiratory distress syndrome are further expected to fuel the global acute respiratory distress syndrome treatment market growth in the forecast period.


However, the presence of limited approved medicines for the treatment of acute respiratory distress syndrome and prominent use of mechanical ventilation devices are factors that can inhibit the growth in global acute respiratory distress syndrome treatment market.


Key Players Covered


The major companies covered in the global acute respiratory distress syndrome treatment market report include Athersys Inc., mondoBIOTECH AG, HEALIOS K.K., GlaxoSmithKline plc., Pfizer Inc., Teva Pharmaceuticals USA Inc., Altor BioScience, Faron Pharmaceuticals, Ltd., and other players.


SEGMENTATION


























SEGMENTATION



 DETAILS



By Drug Class



· Vasoconstrictors


· Bronchodilators


· Steroids and Antibiotics


· Nitric Oxide


· Sedatives & Paralytics


· Surfactant


· Others



By Route of Administration



· Oral


· Injection


· Inhalation



By Distribution Channel



· Hospital Pharmacies


· Retail Pharmacies


· Online Pharmacies


· Others



By Geography



· North America (USA and Canada)


· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)


· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)


· Latin America (Brazil, Mexico and Rest of Latin America)


· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)



 


As per the current acute respiratory distress syndrome treatment market trends, steroids and antibiotics among the drug class segment are anticipated to register a higher market share in the global acute respiratory distress syndrome treatment market owing to the common usage in acute respiratory distress syndrome treatment.


Key Insights



  • Epidemiology of Acute Respiratory Distress Syndrome for Key Countries

  • Applied SWOT Analysis

  • PESTLE Analysis

  • Pipeline Analysis

  • Guideline for Management of Acute Respiratory Distress Syndrome

  • Overview of Inhalation Devices: Acute Respiratory Distress Syndrome

  • Key Mergers and Acquisitions


Regional Analysis


The acute respiratory distress syndrome treatment market is expected to have an exponential growth in North America by the end of 2025 owing to the increased research for the development of new therapy and emerging guidelines for the management of patients with acute respiratory distress syndrome. Altor BioScience, a biopharmaceutical company, is researching an antibody-based tissue factor (TF) antagonist namely ALT-836 for the treatment of infection-induced acute respiratory distress syndrome, which is projected to favor acute respiratory distress syndrome treatment market in North America. In Europe and the Asia Pacific, the acute respiratory distress syndrome treatment market is anticipated to expand due to the increasing prevalence of acute respiratory distress syndrome and a rising number of intensive care units. Additionally, acute respiratory distress syndrome treatment market in Latin America & the Middle East and Africa is in the nascent stage; however, unmet needs for treatment is expected to drive the market growth in this region.


Acute Respiratory Distress Syndrome Treatment Industry Developments



  • In May 2019, Athersys Inc. announced the fast track designation from the U.S. FDA for the MultiStem Program for the treatment of acute respiratory distress syndrome

  • In January 2018, Faron Pharmaceuticals, Ltd. announced that the U.S. FDA granted an Investigational New Drug (IND) application for traumakine, for the treatment of acute respiratory distress syndrome


Acute Respiratory Distress Syndrome Treatment Market Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2020
  • 2017-2019

    CHOOSE LICENSE TYPE

  • $4850
    $6850
    $8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Siemens Healthineers
Amgen
Jubilant
Pfizer
abbvie

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X